 <h1>Pediaderm AF Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>nystatin topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about nystatin topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Pediaderm AF.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nystatin topical: topical cream, topical ointment, topical powder</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nystatin topical (the active ingredient contained in Pediaderm AF) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking nystatin topical:</p><ul>
<li>Skin irritation not present before use of this medicine</li>
</ul><p>
<!-- end topical cream, topical ointment, topical powder --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nystatin topical: topical cream, topical kit, topical ointment, topical powder, vaginal tablet</i></p><h3>Dermatologic</h3><p>Dermatologic side effects associated with nystatin topical (the active ingredient contained in Pediaderm AF) powder, cream, and ointment have included skin irritation, burning, itching, rash, eczema, and pain on application in less than 0.1% of patients.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects associated with nystatin vaginal tablets have included vaginal irritation, burning, and itching.  At least one case of severe vulvovaginitis has also been reported.<sup>[Ref]</sup></p><p>A 64-year-old female experienced severe vulvovaginitis while receiving intravaginal nystatin therapy for Candida glabrata infection.  She was administered nystatin vaginal tablets, 100,000 units twice daily for 14 days.  She returned immediately after having completed the course complaining of intense skin rash in the vulvar area accompanied by severe irritation, burning, and itching.  Therapy with a hydrocortisone cream and intramuscular betamethasone dipropionate was initiated.  A week later, she had marked improvement with clearing of the vulvovaginal erythema and edema.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity side effects associated with nystatin topical (the active ingredient contained in Pediaderm AF) powder, cream, and ointment have included allergic reactions and allergic contact dermatitis in less than 0.1% of patients.  Stevens-Johnson syndrome has also been reported.</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Wasilewski C Jr "Allergic contact dermatitis from nystatin." Arch Dermatol 102 (1970): 216-7</p><p id="ref_2">2. Quirce S, Parra F, Lazaro M, Gomez MI, Sanchez Cano M "Generalized dermatitis due to oral nystatin." Contact Dermatitis 25 (1991): 197-8</p><p id="ref_3">3. Garty BZ "Stevens-Johnson syndrome associated with nystatin treatment." Arch Dermatol 127 (1991): 741-2</p><p id="ref_4">4. "Product Information. Mycostatin Pastilles (nystatin)." Ernest Jackson &amp; Co., Ltd., Crediton, Devon, England,   . </p><p id="ref_5">5. "Product Information. Mycostatin Cream, Mycostatin Topical Powder (nystatin)." Westwood Squibb Pharmaceutical Corporation, Eatontown, NJ. </p><p id="ref_6">6. Wasilewski C Jr "Allergic contact dermatitis from nystatin." Arch Dermatol 104 (1971): 437</p><p id="ref_7">7. Lang E, Goos M "Combined allergy to tolnaftate and nystatin." Contact Dermatitis 12 (1985): 182</p><p id="ref_8">8. de Groot AC, Conemans JM "Nystatin allergy. Petrolatum is not the optimal vehicle for patch testing." Dermatol Clin 8 (1990): 153-5</p><p id="ref_9">9. Hills RJ, Ive FA "Contact sensitivity to nystatin in Timodine." Contact Dermatitis 28 (1993): 48</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Pediaderm AF (nystatin topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>Drug class: topical antifungals</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nystop, Nyamyc, Mycostatin Topical, Pedi-Dri</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Cutaneous Candidiasis</li>
<li>Vaginal Yeast Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nystatin topical: topical cream, topical kit, topical ointment, topical powder, vaginal tablet</i></p><h3>Dermatologic</h3><p>Dermatologic side effects associated with nystatin topical (the active ingredient contained in Pediaderm AF) powder, cream, and ointment have included skin irritation, burning, itching, rash, eczema, and pain on application in less than 0.1% of patients.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects associated with nystatin vaginal tablets have included vaginal irritation, burning, and itching.  At least one case of severe vulvovaginitis has also been reported.<sup>[Ref]</sup></p><p>A 64-year-old female experienced severe vulvovaginitis while receiving intravaginal nystatin therapy for Candida glabrata infection.  She was administered nystatin vaginal tablets, 100,000 units twice daily for 14 days.  She returned immediately after having completed the course complaining of intense skin rash in the vulvar area accompanied by severe irritation, burning, and itching.  Therapy with a hydrocortisone cream and intramuscular betamethasone dipropionate was initiated.  A week later, she had marked improvement with clearing of the vulvovaginal erythema and edema.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity side effects associated with nystatin topical (the active ingredient contained in Pediaderm AF) powder, cream, and ointment have included allergic reactions and allergic contact dermatitis in less than 0.1% of patients.  Stevens-Johnson syndrome has also been reported.</p><p id="ref_1">1. Wasilewski C Jr "Allergic contact dermatitis from nystatin." Arch Dermatol 102 (1970): 216-7</p><p id="ref_2">2. Quirce S, Parra F, Lazaro M, Gomez MI, Sanchez Cano M "Generalized dermatitis due to oral nystatin." Contact Dermatitis 25 (1991): 197-8</p><p id="ref_3">3. Garty BZ "Stevens-Johnson syndrome associated with nystatin treatment." Arch Dermatol 127 (1991): 741-2</p><p id="ref_4">4. "Product Information. Mycostatin Pastilles (nystatin)." Ernest Jackson &amp; Co., Ltd., Crediton, Devon, England,   . </p><p id="ref_5">5. "Product Information. Mycostatin Cream, Mycostatin Topical Powder (nystatin)." Westwood Squibb Pharmaceutical Corporation, Eatontown, NJ. </p><p id="ref_6">6. Wasilewski C Jr "Allergic contact dermatitis from nystatin." Arch Dermatol 104 (1971): 437</p><p id="ref_7">7. Lang E, Goos M "Combined allergy to tolnaftate and nystatin." Contact Dermatitis 12 (1985): 182</p><p id="ref_8">8. de Groot AC, Conemans JM "Nystatin allergy. Petrolatum is not the optimal vehicle for patch testing." Dermatol Clin 8 (1990): 153-5</p><p id="ref_9">9. Hills RJ, Ive FA "Contact sensitivity to nystatin in Timodine." Contact Dermatitis 28 (1993): 48</p><h2>More about Pediaderm AF (nystatin topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>Drug class: topical antifungals</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cutaneous Candidiasis</li>
<li>Vaginal Yeast Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>